Comparative Study of Amniotic Membrane Graft vs Mitomycin C with Conjunctival Autograft for Primary Pterygium Treatment

Not yet recruiting

• Conditions: Pterygium of eye, (2) ICD-10 Condition: O||Medical and Surgical,

• Registration Number: CTRI/2024/05/067752
• Lead Sponsor: Veer Chandra Singh Garhwali Government Institute of Medical Science and Research

Brief Summary

To see the effectiveness in patients having primary pterygium underwent  Amniotic Membrane Graft versus 0.025% Mitomycin C with Conjunctival Autograft.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-10
• Last Update Posted: 2024-10-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Patients diagnosed with primary pterygium.
• Adults (18 years and older).

Exclusion Criteria

• Patients with recurrent pterygium, severe ocular conditions, such as advanced glaucoma, corneal dystrophy, or significant ocular surface disease.
• Combined surgical procedures at the time of surgery like trabeculectomy, cataract surgery.
• Macular degeneration or any other retinal pathology were excluded.
• With systemic connective tissue disorders.
• Inability to give informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graft	Comparison of the effectiveness will be notice at 1 week and 1 month

Secondary Outcome Measures

Name	Time	Method
Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graft	Effectiveness of recurrence after 2 months

Trial Locations

Locations (1)

HNB BASE HOSPITAL; 🇮🇳 Garhwal, UTTARANCHAL, India

HNB BASE HOSPITAL

🇮🇳Garhwal, UTTARANCHAL, India

NIKITA BILANIA

Principal investigator

07300829061

Nikitabilania009@gmail.com